Sign Out
The pre-marketing clinical trials involving REMLEAS in approximately 850 subjects do not provide information regarding symptoms with overdose.
No specific antidotes for REMLEAS are known. In managing overdose, provide supportive care, including close medical supervision and monitoring, and consider the possibility of multiple drug involvement.
